Spotlight on Navitas

The education provider continues to be 'top of the class'.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Global education provider Navitas (ASX: NVT) has just released its results for the full year. It has been a sound performer for a number of years and the latest results appear to still be sound, although shareholders and potential investors could have reason to be wary.

Navitas was founded in the early 1990s by Rod Jones and Peter Larsen, beginning with a single partnership with Edith Cowan University in Perth. Today the firm can boast of programs with 111 colleges and schools, around 5,500 staff and over 80,000 students spanning the globe. Peter Larsen still sits on the board and Rod Jones is still the Chief Executive Officer, positions they have held since the company listed in 2004.

The results release showed that revenues grew 6.3% in financial year 2013 to $731.7 million, net profit after tax (NPAT) grew 1.9% to $74.5 million and earnings per share (EPS) was also up 1.9% to 19.9 cents per share (cps). A final fully franked dividend of 10.2 cents was declared, bringing the total value of dividend paid for the full year to 19.5 cents per share.

A classic example of earnings multiple expansion

Much has been said in the past year about the share market rally being driven by earnings multiple expansion rather than earnings growth. Navitas' share price would look to be a classic case of multiple expansion rather than the result of earnings growth.

In the past five years Navitas' share price has increased by 180%. Over the same time period the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) is up just 4%. Its fabulous share price performance doesn't appear to be matched by the revenue and earnings performance of the company. The full-year results for 2008 were: revenue $345 million, NPAT $37.4 million and EPS 10.8 cps. Comparing these 2008 results with the 2013 results show that both NPAT and EPS are up less than 100% yet the share price has gained 180%.

It's interesting to consider that in August 2011 the market was valuing Navitas at $3.50 per share (although it had spent most of the previous 12 months closer to $4). In August 2012, the share price was again hovering around the $4 level, however since November 2012, the share price has been on a stellar run rocketing from $4 to $6. Over this 2011 to 2013 time period though, EPS have actually declined. That's multiple expansion for you!

Beware of the McMillan Shakespeare effect

There has been much coverage of the potential change in legislation around the Fringe Benefits Tax (FBT) in recent days and the effect this could have on industry participants, including McMillan Shakespeare (ASX: MMS). Investors now have a much clearer understanding of just how exposed a company like McMillan Shakespeare is to the whims of politicians.

Navitas, given its role within the education sector, also finds itself exposed to government policy and those same whimsical politicians. Companies exposed to the risk of regulatory uncertainties deserve to trade at a discount rather than a premium and just as McMillan Shakespeare investors are now asking themselves that very question, so perhaps should Navitas investors.

Foolish takeaway

The results appear to have been what the market was expecting, with the share price hardly budging after the results release.

At $6, Navitas is trading on a dividend yield of 3.25% and a hefty price-to-earnings ratio of 30 times. Of note, the board choose to pay out 98% of earnings as dividends, although a payout ratio future aim of 80% has been declared. With a balance sheet full of intangibles and net debt of $95 million, it is perhaps telling that the company has adopted a dividend reinvestment plan.

2013 now marks the third year of stagnating earnings growth for Navitas. Management is promising "solid growth in FY14" and given the premium pricing of the stock, shareholders will be hoping management delivers. Should a fourth year of flat earnings occur, it is hard to see why the market would continue to place a PE multiple of 30 on the stock.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »